New Delhi, March 26 A study has uncovered a brain-related pathway for how metformin — the first-line treatment for diabetes for over 60 years and not considered to target the brain — regulates blood sugar, opening the door to more targeted therapies."It has been widely accepted that metformin...
baylor college of medicine
blood sugar regulation
brain pathways
diabetes
drug action
drugdevelopment
glucose metabolism
medical research
metformin
rap1 protein
sf1 neurons
study findings
treatment targets
type 2 diabetes
ventromedial hypothalamus
New Delhi, March 25 Pharma major Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime sleepiness.The tentative approval from the US Food and Drug...
abbreviated new drug application
drugdevelopmentdrug manufacturing
excessive daytime sleepiness
generic pharmaceuticals
healthcare
india
lupin ltd
nagpur
pharmaceutical approval
pharmaceutical industry
pitolisant
regulatory filings
tablet
us food and drug administration (usfda)
New Delhi, March 23 A study has identified a new biomarker for schizophrenia, which could also serve as a target for drugs to treat cognitive symptoms such as disorganized thinking or executive function.Schizophrenia is a mental health disorder characterized by an impaired ability to perceive...
New Delhi, March 13 Researchers have discovered a new chemical reaction that spontaneously forms and breaks a sulfur-sulfur bond at room temperature, with potential applications in drug development, protein science, biotechnology, and chemical and material science.The bond has previously been...
anti-cancer drugs
biotechnology
chemical modification
chemical reaction
chemical science
drugdevelopment
flinders university
material science
nature chemistry
polymer chemistry
protein science
recyclable polymers
solvent effects
sulfur-sulfur bond
trisulfide metathesis
New Delhi, March 3 NATCO Pharma announced on Tuesday the launch of generic Pomalidomide capsules in the US market, indicated for the treatment of adult patients with blood and bone marrow cancer, in partnership with Breckenridge Pharmaceutical, Inc.Pomalidomide capsule is a generic version of...
blood cancer
bone marrow cancer
breckenridge pharmaceutical
cancer treatment
drugdevelopment
fda approval
generic pharmaceuticals
hiv
kaposi sarcoma
multiple myeloma
natco pharma
pharmaceutical products
pomalidomide
specialty pharmacies
us market
Mumbai, February 28 Researchers at the Indian Institute of Technology Bombay (IIT Bombay) have found that analyzing where antibiotics accumulate within the outer layers of liver cells can serve as an early indicator of drug-induced toxicity, which can help in faster detection of harmful side...
Washington, February 28 – A bipartisan US Senate panel criticized the Food and Drug Administration (FDA) for delays and shifting standards that witnesses said are hindering treatments for rare diseases, warning that “time is the most precious commodity” for families and that “patients with rare...
21st century cures act
accelerated approval pathway
clinical data
clinical trials
drugdevelopment
fda approval process
food and drug administration
orphan drug act
patient advocacy
pompe disease
rare diseases
real-world evidence
regulatory flexibility
senate committee on aging
troriluzole
New Delhi, February 19 Zydus Lifesciences announced on Thursday that it has launched its first biosimilar, developed indigenously, for the treatment of visual impairment.Anyra, the country's first biosimilar of Aflibercept 2 mg, is indicated for the treatment of visual impairment caused by...
New Delhi, February 10 Syngene International announced on Tuesday that it has entered into a partnership with Johns Hopkins University to advance early-stage drug discovery programs and platform technologies emerging from the university's research labs.The collaboration will be delivered by...